| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 149, 293-305, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
DR Senger, SR Ledbetter, KP Claffey, A Papadopoulos-Sergiou, CA Peruzzi and M Detmar
Department of Pathology, Beth Israel Hospital, Boston, Massachusetts, USA.
We have identified several mechanisms by which the angiogenic cytokine vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) likely regulates endothelial cells (EC) migration. VPF/VEGF induced dermal microvascular EC expression of mRNAs encoding the alphav and beta3 integrin subunits resulting in increased levels of the alphavbeta3 heterodimer at the cell surface, and VPF/VEGF also induced mRNA encoding osteopontin (OPN), an alphavbeta3 ligand. OPN promoted EC migration in vitro; and VPF/VEGF induction of alphavbeta3 was accompanied by increased EC migration toward OPN. Because thrombin cleavage of OPN results in substantial enhancement of OPN's adhesive properties, and because VPF/VEGF promotes increased microvascular permeability leading to activation of the extrinsic coagulation pathway, we also investigated whether VPF/VEGF facilitates thrombin cleavage of OPN in vivo. Consistent with this hypothesis, co-injection of VPF/VEGF together with OPN resulted in rapid cleavage of OPN by endogenous thrombin. Furthermore, in comparison with native OPN, thrombin-cleaved OPN stimulated a greater rate of EC migration in vitro, which was additive to the increased migration associated with induction of alpha v beta 3. Thus, these data demonstrate cooperative mechanisms for VPF/VEGF regulation of EC migration involving the alphavbeta3 integrin, the alphavbeta3 ligand OPN, and thrombin cleavage of OPN. These findings also illustrate an operational link between VPF/VEGF induction of EC gene expression and VPF/VEGF enhancement of microvascular permeability, suggesting that these distinct biological activities may act accordingly to stimulate EC migration during angiogenesis.
This article has been cited by other articles:
![]() |
S. Fischer, M. Nishio, S. C. Peters, M. Tschernatsch, M. Walberer, S. Weidemann, R. Heidenreich, P. O. Couraud, B. B. Weksler, I. A. Romero, et al. Signaling mechanism of extracellular RNA in endothelial cells FASEB J, July 1, 2009; 23(7): 2100 - 2109. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. BOSCO, S. DELFINO, F. FERLITO, M. PUPPO, A. GREGORIO, C. GAMBINI, M. GATTORNO, A. MARTINI, and L. VARESIO The Hypoxic Synovial Environment Regulates Expression of Vascular Endothelial Growth Factor and Osteopontin in Juvenile Idiopathic Arthritis J Rheumatol, June 1, 2009; 36(6): 1318 - 1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bhattacharya, J. Kwon, X. Li, E. Wang, S. Patra, J. P. Bida, Z. Bajzer, L. Claesson-Welsh, and D. Mukhopadhyay Distinct role of PLC{beta}3 in VEGF-mediated directional migration and vascular sprouting J. Cell Sci., April 1, 2009; 122(7): 1025 - 1034. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. HASEGAWA, Y. NAKOSHI, T. IINO, A. SUDO, T. SEGAWA, M. MAEDA, T. YOSHIDA, and A. UCHIDA Thrombin-Cleaved Osteopontin in Synovial Fluid of Subjects with Rheumatoid Arthritis J Rheumatol, February 1, 2009; 36(2): 240 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Villares, M. Zigler, H. Wang, V. O. Melnikova, H. Wu, R. Friedman, M. C. Leslie, P. E. Vivas-Mejia, G. Lopez-Berestein, A. K. Sood, et al. Targeting Melanoma Growth and Metastasis with Systemic Delivery of Liposome-Incorporated Protease-Activated Receptor-1 Small Interfering RNA Cancer Res., November 1, 2008; 68(21): 9078 - 9086. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cheng, H. Zhang, X. Yang, E. Tzima, K. L. Ewalt, P. Schimmel, and J. E. Faber Effect of mini-tyrosyl-tRNA synthetase on ischemic angiogenesis, leukocyte recruitment, and vascular permeability Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1138 - R1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. N. Gavrilovskaya, E. E. Gorbunova, N. A. Mackow, and E. R. Mackow Hantaviruses Direct Endothelial Cell Permeability by Sensitizing Cells to the Vascular Permeability Factor VEGF, while Angiopoietin 1 and Sphingosine 1-Phosphate Inhibit Hantavirus-Directed Permeability J. Virol., June 15, 2008; 82(12): 5797 - 5806. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Barkefors, S. Le Jan, L. Jakobsson, E. Hejll, G. Carlson, H. Johansson, J. Jarvius, J. W. Park, N. Li Jeon, and J. Kreuger Endothelial Cell Migration in Stable Gradients of Vascular Endothelial Growth Factor A and Fibroblast Growth Factor 2: EFFECTS ON CHEMOTAXIS AND CHEMOKINESIS J. Biol. Chem., May 16, 2008; 283(20): 13905 - 13912. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kalinowski, L. W. Dobrucki, D. F. Meoli, D. P. Dione, M. M. Sadeghi, J. A. Madri, and A. J. Sinusas Targeted imaging of hypoxia-induced integrin activation in myocardium early after infarction J Appl Physiol, May 1, 2008; 104(5): 1504 - 1512. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yan, B. Bentley, and R. Shao Distinct Angiogenic Mediators Are Required for Basic Fibroblast Growth Factor- and Vascular Endothelial Growth Factor-induced Angiogenesis: The Role of Cytoplasmic Tyrosine Kinase c-Abl in Tumor Angiogenesis Mol. Biol. Cell, May 1, 2008; 19(5): 2278 - 2288. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Duvall, D. Weiss, S. T. Robinson, F. M.F. Alameddine, R. E. Guldberg, and W. R. Taylor The Role of Osteopontin in Recovery from Hind Limb Ischemia Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): 290 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chakraborty, S. Jain, and G. C. Kundu Osteopontin Promotes Vascular Endothelial Growth Factor Dependent Breast Tumor Growth and Angiogenesis via Autocrine and Paracrine Mechanisms Cancer Res., January 1, 2008; 68(1): 152 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Lwaleed, A. J. Cooper, D. Voegeli, and K. Getliffe Tissue Factor: A Critical Role in Inflammation and Cancer Biol Res Nurs, October 1, 2007; 9(2): 97 - 107. [Abstract] [PDF] |
||||
![]() |
S. Fischer, T. Gerriets, C. Wessels, M. Walberer, S. Kostin, E. Stolz, K. Zheleva, A. Hocke, S. Hippenstiel, and K. T. Preissner Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor Blood, October 1, 2007; 110(7): 2457 - 2465. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Brakenhielm Substrate Matters: Reciprocally Stimulatory Integrin and VEGF Signaling in Endothelial Cells Circ. Res., September 14, 2007; 101(6): 536 - 538. [Full Text] [PDF] |
||||
![]() |
D. Leali, E. Moroni, F. Bussolino, and M. Presta Osteopontin Overexpression Inhibits in Vitro Re-endothelialization via Integrin Engagement J. Biol. Chem., July 6, 2007; 282(27): 19676 - 19684. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gillibert-Duplantier, V. Neaud, J.-F. Blanc, P. Bioulac-Sage, and J. Rosenbaum Thrombin inhibits migration of human hepatic myofibroblasts Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G128 - G136. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Rodrigues, J. A. Teixeira, F. L. Schmitt, M. Paulsson, and H. Lindmark-Mansson The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1087 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tanaka, M. Abe, M. Hiasa, A. Oda, H. Amou, A. Nakano, K. Takeuchi, K. Kitazoe, S. Kido, D. Inoue, et al. Myeloma Cell-Osteoclast Interaction Enhances Angiogenesis Together with Bone Resorption: A Role for Vascular Endothelial Cell Growth Factor and Osteopontin Clin. Cancer Res., February 1, 2007; 13(3): 816 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-H. Lee, S. Seng, H. Li, S. J. Kennel, H. K. Avraham, and S. Avraham Integrin Regulation by Vascular Endothelial Growth Factor in Human Brain Microvascular Endothelial Cells: ROLE OF {alpha}6beta1 INTEGRIN IN ANGIOGENESIS J. Biol. Chem., December 29, 2006; 281(52): 40450 - 40460. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pal, J. Wu, J. K. Murray, S. H. Gellman, M. A. Wozniak, P. J. Keely, M. E. Boyer, T. M. Gomez, S. M. Hasso, J. F. Fallon, et al. An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis J. Cell Biol., September 25, 2006; 174(7): 1047 - 1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Cook, A. F. Chambers, E. A. Turley, and A. B. Tuck Osteopontin Induction of Hyaluronan Synthase 2 Expression Promotes Breast Cancer Malignancy J. Biol. Chem., August 25, 2006; 281(34): 24381 - 24389. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yan and R. Shao Transduction of a Mesenchyme-specific Gene Periostin into 293T Cells Induces Cell Invasive Activity through Epithelial-Mesenchymal Transformation J. Biol. Chem., July 14, 2006; 281(28): 19700 - 19708. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Penn, G. W. McCollum, J. M. Barnett, X. Q. Werdich, K. A. Koepke, and V. S. Rajaratnam Angiostatic Effect of Penetrating Ocular Injury: Role of Pigment Epithelium-Derived Factor Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 405 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Summy, J. G. Trevino, D. P. Lesslie, C. H. Baker, W. C. Shakespeare, Y. Wang, R. Sundaramoorthi, C. A. Metcalf III, J. A. Keats, T. K. Sawyer, et al. AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes Mol. Cancer Ther., December 1, 2005; 4(12): 1900 - 1911. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Davis and D. R. Senger Endothelial Extracellular Matrix: Biosynthesis, Remodeling, and Functions During Vascular Morphogenesis and Neovessel Stabilization Circ. Res., November 25, 2005; 97(11): 1093 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Abel, S. Freigang, M. F. Bachmann, U. Boschert, and M. Kopf Osteopontin Is Not Required for the Development of Th1 Responses and Viral Immunity J. Immunol., November 1, 2005; 175(9): 6006 - 6013. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Wilgus, A. M. Matthies, K. A. Radek, J. V. Dovi, A. L. Burns, R. Shankar, and L. A. DiPietro Novel Function for Vascular Endothelial Growth Factor Receptor-1 on Epidermal Keratinocytes Am. J. Pathol., November 1, 2005; 167(5): 1257 - 1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Scarlato, S. C. Previtali, M. Carpo, D. Pareyson, C. Briani, R. Del Bo, E. Nobile-Orazio, A. Quattrini, and G. P. Comi Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis Brain, August 1, 2005; 128(8): 1911 - 1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Renkl, J. Wussler, T. Ahrens, K. Thoma, S. Kon, T. Uede, S. F. Martin, J. C. Simon, and J. M. Weiss Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype Blood, August 1, 2005; 106(3): 946 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Wedge, J. Kendrew, L. F. Hennequin, P. J. Valentine, S. T. Barry, S. R. Brave, N. R. Smith, N. H. James, M. Dukes, J. O. Curwen, et al. AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer Cancer Res., May 15, 2005; 65(10): 4389 - 4400. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mentor-Marcel, C. A. Lamartiniere, I. A. Eltoum, N. M. Greenberg, and A. Elgavish Dietary Genistein Improves Survival and Reduces Expression of Osteopontin in the Prostate of Transgenic Mice with Prostatic Adenocarcinoma (TRAMP) J. Nutr., May 1, 2005; 135(5): 989 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Seipelt, C. L. Backer, C. Mavroudis, V. Stellmach, M. Cornwell, I. M. Seipelt, F. A. Schoendube, and S. E. Crawford Osteopontin expression and adventitial angiogenesis induced by local vascular endothelial growth factor 165 reduces experimental aortic calcification J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 773 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Y. Wai, Z. Mi, H. Guo, S. Sarraf-Yazdi, C. Gao, J. Wei, C. E. Marroquin, B. Clary, and P. C. Kuo Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis Carcinogenesis, April 1, 2005; 26(4): 741 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-A. Renault, S. Jalvy, M. Potier, I. Belloc, E. Genot, L. V. Dekker, C. Desgranges, and A.-P. Gadeau UTP Induces Osteopontin Expression through a Coordinate Action of NF{kappa}B, Activator Protein-1, and Upstream Stimulatory Factor in Arterial Smooth Muscle Cells J. Biol. Chem., January 28, 2005; 280(4): 2708 - 2713. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lynch, P. I. Vodyanik, D. Boettiger, and M. A. Guvakova Insulin-like Growth Factor I Controls Adhesion Strength Mediated by {alpha}5{beta}1 Integrins in Motile Carcinoma Cells Mol. Biol. Cell, January 1, 2005; 16(1): 51 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E Spencer, G. A Johnson, F. W Bazer, and R. C Burghardt Implantation mechanisms: insights from the sheep Reproduction, December 1, 2004; 128(6): 657 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Collin-Osdoby Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and Osteoprotegerin Circ. Res., November 26, 2004; 95(11): 1046 - 1057. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hu, M. Lee, W. Campbell, R. Perez-Soler, and S. Karpatkin Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis Blood, November 1, 2004; 104(9): 2746 - 2751. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gattorno, A. Gregorio, F. Ferlito, V. Gerloni, A. Parafioriti, E. Felici, E. Sala, C. Gambini, P. Picco, and A. Martini Synovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis Rheumatology, September 1, 2004; 43(9): 1091 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Krikun, D. Sakkas, F. Schatz, L. Buchwalder, D. Hylton, C. Tang, and C. J. Lockwood Endometrial Angiopoietin Expression and Modulation by Thrombin and Steroid Hormones: A Mechanism for Abnormal Angiogenesis Following Long-Term Progestin-Only Contraception Am. J. Pathol., June 1, 2004; 164(6): 2101 - 2107. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wang, C. Jiao, H. D. Hanlon, W. Zheng, R. J. Tomanek, and G. C. Schatteman Mechanical, cellular, and molecular factors interact to modulate circulating endothelial cell progenitors Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1985 - H1993. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Brown, J. Gaspar, A. Pettit, R. Lee, X. Gu, H. Wang, C. Manning, C. Voland, S. R. Goldring, M. B. Goldring, et al. ESE-1 Is a Novel Transcriptional Mediator of Angiopoietin-1 Expression in the Setting of Inflammation J. Biol. Chem., March 26, 2004; 279(13): 12794 - 12803. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. V. Ho, J. J. Jang, S. Kaji, G. Spektor, A. Fong, P. Yang, B. S. Hu, R. Schatzman, T. Quertermous, and J. P. Cooke Developmental Endothelial Locus-1 (Del-1), a Novel Angiogenic Protein: Its Role in Ischemia Circulation, March 16, 2004; 109(10): 1314 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Hoang, M. C. Whelan, and D. R. Senger Rho activity critically and selectively regulates endothelial cell organization during angiogenesis PNAS, February 17, 2004; 101(7): 1874 - 1879. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Witmer, B. C. van Blijswijk, C. J.F. van Noorden, G. F.J.M. Vrensen, and R. O. Schlingemann In Vivo Angiogenic Phenotype of Endothelial Cells and Pericytes Induced by Vascular Endothelial Growth Factor-A J. Histochem. Cytochem., January 1, 2004; 52(1): 39 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tellez, M. McCarty, M. Ruiz, and M. Bar-Eli Loss of Activator Protein-2{alpha} Results in Overexpression of Protease-activated Receptor-1 and Correlates with the Malignant Phenotype of Human Melanoma J. Biol. Chem., November 21, 2003; 278(47): 46632 - 46642. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-A. Renault, S. Jalvy, I. Belloc, S. Pasquet, S. Sena, M. Olive, C. Desgranges, and A.-P. Gadeau AP-1 Is Involved in UTP-Induced Osteopontin Expression in Arterial Smooth Muscle Cells Circ. Res., October 3, 2003; 93(7): 674 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Orecchia, P. M. Lacal, C. Schietroma, V. Morea, G. Zambruno, and C. M. Failla Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the {alpha}5{beta}1 integrin J. Cell Sci., September 1, 2003; 116(17): 3479 - 3489. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Leali, P. Dell'Era, H. Stabile, B. Sennino, A. F. Chambers, A. Naldini, S. Sozzani, B. Nico, D. Ribatti, and M. Presta Osteopontin (Eta-1) and Fibroblast Growth Factor-2 Cross-Talk in Angiogenesis J. Immunol., July 15, 2003; 171(2): 1085 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moser and C. Patterson Thrombin and Vascular Development: A Sticky Subject Arterioscler Thromb Vasc Biol, June 1, 2003; 23(6): 922 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Hotchkiss, A. W. Ashton, and E. L. Schwartz Thymidine Phosphorylase and 2-Deoxyribose Stimulate Human Endothelial Cell Migration by Specific Activation of the Integrins {alpha}5{beta}1 and {alpha}V{beta}3 J. Biol. Chem., May 23, 2003; 278(21): 19272 - 19279. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Chellaiah, N. Kizer, R. Biswas, U. Alvarez, J. Strauss-Schoenberger, L. Rifas, S. R. Rittling, D. T. Denhardt, and K. A. Hruska Osteopontin Deficiency Produces Osteoclast Dysfunction Due to Reduced CD44 Surface Expression Mol. Biol. Cell, January 1, 2003; 14(1): 173 - 189. [Abstract] [Full Text] |
||||
![]() |
R. Rocha, C. L. Martin-Berger, P. Yang, R. Scherrer, J. Delyani, and E. McMahon Selective Aldosterone Blockade Prevents Angiotensin II/Salt-Induced Vascular Inflammation in the Rat Heart Endocrinology, December 1, 2002; 143(12): 4828 - 4836. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Weber, S. Zawaideh, S. Hikita, V. A. Kumar, H. Cantor, and S. Ashkar Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation J. Leukoc. Biol., October 1, 2002; 72(4): 752 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Smyth and C. Patterson Tiny dancers: the integrin-growth factor nexus in angiogenic signaling J. Cell Biol., July 8, 2002; 158(1): 17 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lin, J. LeCouter, J. Kowalski, and N. Ferrara Characterization of Endocrine Gland-derived Vascular Endothelial Growth Factor Signaling in Adrenal Cortex Capillary Endothelial Cells J. Biol. Chem., March 1, 2002; 277(10): 8724 - 8729. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Oyama, N. Akuzawa, R. Nagai, and M. Kurabayashi PPAR{gamma} Ligand Inhibits Osteopontin Gene Expression Through Interference With Binding of Nuclear Factors to A/T-Rich Sequence in THP-1 Cells Circ. Res., February 22, 2002; 90(3): 348 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.D. HOOD and D.A. CHERESH Targeted Delivery of Mutant Raf Kinase to Neovessels Causes Tumor Regression Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 285 - 292. [Abstract] [PDF] |
||||
![]() |
D. R. Senger, C. A. Perruzzi, M. Streit, V. E. Koteliansky, A. R. de Fougerolles, and M. Detmar The {alpha}1{beta}1 and {alpha}2{beta}1 Integrins Provide Critical Support for Vascular Endothelial Growth Factor Signaling, Endothelial Cell Migration, and Tumor Angiogenesis Am. J. Pathol., January 1, 2002; 160(1): 195 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Eliceiri Integrin and Growth Factor Receptor Crosstalk Circ. Res., December 7, 2001; 89(12): 1104 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bello, V. Lucini, G. Carrabba, C. Giussani, M. Machluf, M. Pluderi, D. Nikas, J. Zhang, G. Tomei, R. M. Villani, et al. Simultaneous Inhibition of Glioma Angiogenesis, Cell Proliferation, and Invasion by a Naturally Occurring Fragment of Human Metalloproteinase-2 Cancer Res., December 1, 2001; 61(24): 8730 - 8736. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.M. Weiss, A.C. Renkl, C.S. Maier, M. Kimmig, L. Liaw, T. Ahrens, S. Kon, M. Maeda, H. Hotta, T. Uede, et al. Osteopontin Is Involved in the Initiation of Cutaneous Contact Hypersensitivity by Inducing Langerhans and Dendritic Cell Migration to Lymph Nodes J. Exp. Med., October 29, 2001; 194(9): 1219 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Rupp and C. D. Little Integrins in Vascular Development Circ. Res., September 28, 2001; 89(7): 566 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bassus, O. Herkert, N. Kronemann, A. Gorlach, D. Bremerich, C. M. Kirchmaier, R. Busse, and V. B. Schini-Kerth Thrombin Causes Vascular Endothelial Growth Factor Expression in Vascular Smooth Muscle Cells: Role of Reactive Oxygen Species Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1550 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Skobe, L. M. Hamberg, T. Hawighorst, M. Schirner, G. L. Wolf, K. Alitalo, and M. Detmar Concurrent Induction of Lymphangiogenesis, Angiogenesis, and Macrophage Recruitment by Vascular Endothelial Growth Factor-C in Melanoma Am. J. Pathol., September 1, 2001; 159(3): 893 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saito, M. P. Pelletier, H. Shennib, and A. Giaid Nitric oxide system in needle-induced transmyocardial revascularization Ann. Thorac. Surg., July 1, 2001; 72(1): 129 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sun, M. Vitolo, and A. Passaniti Runt-related Gene 2 in Endothelial Cells: Inducible Expression and Specific Regulation of Cell Migration and Invasion Cancer Res., July 1, 2001; 61(13): 4994 - 5001. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Takahashi, K. Takahashi, T. Okazaki, K. Maeda, H. Ienaga, M. Maeda, S. Kon, T. Uede, and Y. Fukuchi Role of Osteopontin in the Pathogenesis of Bleomycin-Induced Pulmonary Fibrosis Am. J. Respir. Cell Mol. Biol., March 1, 2001; 24(3): 264 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Asou, S. R. Rittling, H. Yoshitake, K. Tsuji, K. Shinomiya, A. Nifuji, D. T. Denhardt, and M. Noda Osteopontin Facilitates Angiogenesis, Accumulation of Osteoclasts, and Resorption in Ectopic Bone Endocrinology, March 1, 2001; 142(3): 1325 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Ali, A. L. ODonnell, D. Balu, M. B. Pohl, M. J. Seyler, S. Mohamed, S. Mousa, and P. Dandona Estrogen Receptor-{{alpha}} in the Inhibition of Cancer Growth and Angiogenesis Cancer Res., December 1, 2000; 60(24): 7094 - 7098. [Abstract] [Full Text] |
||||
![]() |
A. Sahni and C. W. Francis Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation Blood, December 1, 2000; 96(12): 3772 - 3778. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fischer, M. Wobben, J. Kleinstuck, D. Renz, and W. Schaper Effect of astroglial cells on hypoxia-induced permeability in PBMEC cells Am J Physiol Cell Physiol, October 1, 2000; 279(4): C935 - C944. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Senger and L. Van De Water VEGF Expression by Epithelial and Stromal Cell Compartments : Resolving a Controversy Am. J. Pathol., July 1, 2000; 157(1): 1 - 3. [Full Text] [PDF] |
||||
![]() |
G. A. Johnson, T. E. Spencer, R. C. Burghardt, K. M. Taylor, C. A. Gray, and F. W. Bazer Progesterone Modulation of Osteopontin Gene Expression in the Ovine Uterus Biol Reprod, May 1, 2000; 62(5): 1315 - 1321. [Abstract] [Full Text] |
||||
![]() |
M. A. Chellaiah, N. Soga, S. Swanson, S. McAllister, U. Alvarez, D. Wang, S. F. Dowdy, and K. A. Hruska Rho-A Is Critical for Osteoclast Podosome Organization, Motility, and Bone Resorption J. Biol. Chem., April 14, 2000; 275(16): 11993 - 12002. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chellaiah, N. Kizer, M. Silva, U. Alvarez, D. Kwiatkowski, and K. A. Hruska Gelsolin Deficiency Blocks Podosome Assembly and Produces Increased Bone Mass and Strength J. Cell Biol., February 21, 2000; 148(4): 665 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ashkar, G. F. Weber, V. Panoutsakopoulou, M. E. Sanchirico, M. Jansson, S. Zawaideh, S. R. Rittling, D. T. Denhardt, M. J. Glimcher, and H. Cantor Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) Immunity Science, February 4, 2000; 287(5454): 860 - 864. [Abstract] [Full Text] |
||||
![]() |
S. R. Wedge, D. J. Ogilvie, M. Dukes, J. Kendrew, J. O. Curwen, L. F. Hennequin, A. P. Thomas, E. S. E. Stokes, B. Curry, G. H. P. Richmond, et al. ZD4190: An Orally Active Inhibitor of Vascular Endothelial Growth Factor Signaling with Broad-Spectrum Antitumor Efficacy Cancer Res., February 1, 2000; 60(4): 970 - 975. [Abstract] [Full Text] |
||||
![]() |
N. Munshi, J. E. Groopman, P. S. Gill, and R. K. Ganju c-Src Mediates Mitogenic Signals and Associates with Cytoskeletal Proteins upon Vascular Endothelial Growth Factor Stimulation in Kaposi's Sarcoma Cells J. Immunol., February 1, 2000; 164(3): 1169 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Peichev, A. J. Naiyer, D. Pereira, Z. Zhu, W. J. Lane, M. Williams, M. C. Oz, D. J. Hicklin, L. Witte, M. A. S. Moore, et al. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors Blood, February 1, 2000; 95(3): 952 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. V. Diaz, M.-C. Lenoir, A. Ladoux, C. Frelin, M. Demarchez, and S. Michel Regulation of Vascular Endothelial Growth Factor Expression in Human Keratinocytes by Retinoids J. Biol. Chem., January 7, 2000; 275(1): 642 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sodek, B. Ganss, and M.D. McKee Osteopontin Critical Reviews in Oral Biology & Medicine, January 1, 2000; 11(3): 279 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Montrucchio, E. Lupia, E. Battaglia, L. Del Sorbo, M. Boccellino, L. Biancone, G. Emanuelli, and G. Camussi Platelet-Activating Factor Enhances Vascular Endothelial Growth Factor-Induced Endothelial Cell Motility and Neoangiogenesis in a Murine Matrigel Model Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 80 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Detmar, P. Velasco, L. Richard, K. P. Claffey, M. Streit, L. Riccardi, M. Skobe, and L. F. Brown Expression of Vascular Endothelial Growth Factor Induces an Invasive Phenotype in Human Squamous Cell Carcinomas Am. J. Pathol., January 1, 2000; 156(1): 159 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Streit, L. Riccardi, P. Velasco, L. F. Brown, T. Hawighorst, P. Bornstein, and M. Detmar Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis PNAS, December 21, 1999; 96(26): 14888 - 14893. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. SHIJUBO, T. UEDE, S. KON, M. MAEDA, T. SEGAWA, A. IMADA, M. HIRASAWA, and S. ABE Vascular Endothelial Growth Factor and Osteopontin in Stage I Lung Adenocarcinoma Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1269 - 1273. [Abstract] [Full Text] |
||||
![]() |
G. A. Johnson, R. C. Burghardt, T. E. Spencer, G. R. Newton, T. L. Ott, and F. W. Bazer Ovine Osteopontin: II. Osteopontin and {alpha}v{beta}3 Integrin Expression in the Uterus and Conceptus During the Periimplantation Period Biol Reprod, October 1, 1999; 61(4): 892 - 899. [Abstract] [Full Text] |
||||
![]() |
N. Kronemann, A. Bouloumie, S. Bassus, C. M. Kirchmaier, R. Busse, and V. B. Schini-Kerth Aggregating Human Platelets Stimulate Expression of Vascular Endothelial Growth Factor in Cultured Vascular Smooth Muscle Cells Through a Synergistic Effect of Transforming Growth Factor-{beta}1 and Platelet-Derived Growth FactorAB Circulation, August 24, 1999; 100(8): 855 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Luo, G. Paranya, and J. Bischoff Noninflammatory Expression of E-Selectin Is Regulated by Cell Growth Blood, June 1, 1999; 93(11): 3785 - 3791. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Solovey, L. Gui, S. Ramakrishnan, M. H. Steinberg, and R. P. Hebbel Sickle Cell Anemia as a Possible State of Enhanced Anti-Apoptotic Tone: Survival Effect of Vascular Endothelial Growth Factor on Circulating and Unanchored Endothelial Cells Blood, June 1, 1999; 93(11): 3824 - 3830. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Murohara, B. Witzenbichler, I. Spyridopoulos, T. Asahara, B. Ding, A. Sullivan, D. W. Losordo, and J. M. Isner Role of Endothelial Nitric Oxide Synthase in Endothelial Cell Migration Arterioscler Thromb Vasc Biol, May 1, 1999; 19(5): 1156 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fischer, M. Clauss, M. Wiesnet, D. Renz, W. Schaper, and G. F. Karliczek Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO Am J Physiol Cell Physiol, April 1, 1999; 276(4): C812 - C820. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Balbay, C. A. Pettaway, H. Kuniyasu, K. Inoue, E. Ramirez, E. Li, I. J. Fidler, and C. P. N. Dinney Highly Metastatic Human Prostate Cancer Growing within the Prostate of Athymic Mice Overexpresses Vascular Endothelial Growth Factor Clin. Cancer Res., April 1, 1999; 5(4): 783 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Collo and M. Pepper Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro J. Cell Sci., January 2, 1999; 112(4): 569 - 578. [Abstract] [PDF] |
||||
![]() |
L. Ma, J. Y. C. Chow, and C. H. Cho Cigarette smoking delays ulcer healing: role of constitutive nitric oxide synthase in rat stomach Am J Physiol Gastrointest Liver Physiol, January 1, 1999; 276(1): G238 - G248. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ellison, J. J. Velier, P. Spera, Z. L. Jonak, X. Wang, F. C. Barone, G. Z. Feuerstein, T. Abumiya, and G. J. del Zoppo Osteopontin and its Integrin Receptor {alpha}vß3 Are Upregulated During Formation of the Glial Scar After Focal Stroke • Editorial Comment Stroke, August 1, 1998; 29(8): 1698 - 1707. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Baumgartner, A. Pieczek, O. Manor, R. Blair, M. Kearney, K. Walsh, and J. M. Isner Constitutive Expression of phVEGF165 After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb Ischemia Circulation, March 31, 1998; 97(12): 1114 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Eliceiri, R. Klemke, S. Stromblad, and D. A. Cheresh Integrin {alpha}v{beta}3 Requirement for Sustained Mitogen-activated Protein Kinase Activity during Angiogenesis J. Cell Biol., March 9, 1998; 140(5): 1255 - 1263. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |